- Home
- NKTR vs MPA Comparison
NKTR vs MPA Comparison
Compare NKTR & MPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTR
- MPA
- Stock Information
- Founded
- NKTR 1990
- MPA 1992
- Country
- NKTR United States
- MPA United States
- Employees
- NKTR N/A
- MPA N/A
- Industry
- NKTR Biotechnology: Pharmaceutical Preparations
- MPA Finance Companies
- Sector
- NKTR Health Care
- MPA Finance
- Exchange
- NKTR Nasdaq
- MPA Nasdaq
- Market Cap
- NKTR 125.5M
- MPA 139.0M
- IPO Year
- NKTR 1994
- MPA N/A
- Fundamental
- Price
- NKTR $8.51
- MPA $10.78
- Analyst Decision
- NKTR Strong Buy
- MPA
- Analyst Count
- NKTR 6
- MPA 0
- Target Price
- NKTR $73.75
- MPA N/A
- AVG Volume (30 Days)
- NKTR 348.5K
- MPA 25.2K
- Earning Date
- NKTR 08-07-2025
- MPA 01-01-0001
- Dividend Yield
- NKTR N/A
- MPA 3.83%
- EPS Growth
- NKTR N/A
- MPA N/A
- EPS
- NKTR N/A
- MPA N/A
- Revenue
- NKTR $87,248,000.00
- MPA N/A
- Revenue This Year
- NKTR N/A
- MPA N/A
- Revenue Next Year
- NKTR N/A
- MPA N/A
- P/E Ratio
- NKTR N/A
- MPA N/A
- Revenue Growth
- NKTR N/A
- MPA N/A
- 52 Week Low
- NKTR $6.48
- MPA $9.87
- 52 Week High
- NKTR $22.79
- MPA $12.21
- Technical
- Relative Strength Index (RSI)
- NKTR 42.19
- MPA 47.36
- Support Level
- NKTR $7.99
- MPA $10.65
- Resistance Level
- NKTR $9.71
- MPA $10.80
- Average True Range (ATR)
- NKTR 1.37
- MPA 0.09
- MACD
- NKTR -0.20
- MPA 0.00
- Stochastic Oscillator
- NKTR 11.66
- MPA 48.15
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.
About MPA Blackrock MuniYield Pennsylvania Quality Fund
Blackrock Muniyield Pennsylvania Quality Fund is a closed-end fund with investment objective is to provide shareholders with current income exempt from U.S. federal and Pennsylvania income taxes.